These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3283257)

  • 1. Effect of hyperbaric oxygenation, combined with antimicrobial agents and surgery, in a rat model of intraabdominal infection.
    Muhvich KH; Myers RA; Marzella L
    J Infect Dis; 1988 May; 157(5):1058-61. PubMed ID: 3283257
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hyperbaric oxygen and surgery on experimental multimicrobial gas gangrene.
    Hirn M; Niinikoski J; Lehtonen OP
    Eur Surg Res; 1993; 25(5):265-9. PubMed ID: 8404985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent hyperbaric oxygen therapy for reduction of mortality in experimental polymicrobial sepsis.
    Thom SR; Lauermann MW; Hart GB
    J Infect Dis; 1986 Sep; 154(3):504-10. PubMed ID: 3090159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental model of intraabdominal abscess in the rat.
    Fry DE; Garrison RN; Rink RD; Casey J; DeCamp MM; Richardson JD
    Adv Shock Res; 1982; 7():7-11. PubMed ID: 6753539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of temafloxacin in a rat model of intra-abdominal abscess.
    Thadepalli H; Hajji M; Perumal VK; Chuah SK; Gollapudi S
    J Antimicrob Chemother; 1992 Jun; 29(6):687-92. PubMed ID: 1324241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hyperbaric oxygenation on experimental Bacteroides fragilis infection in the rat liver.
    Tønjum S; Svanes K; Alho A; Hofstad T
    Acta Chir Scand; 1981; 147(5):347-51. PubMed ID: 7324761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of hip septic arthritis due to Bacteroides fragilis in an alcoholic patient.
    Merle-Melet M; Mainard D; Regent D; Dopff C; Tamisier JN; Ross P; Delagoutte JP; Gerard A
    Infection; 1994; 22(5):353-5. PubMed ID: 7843815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
    Huelves L; Gracia M; Del Prado G; Rodríguez-Cerrato V; Martínez-Marín C; Ponte C; Soriano F; Coronel P; Gimeno M; Blanco J
    Int J Antimicrob Agents; 2006 Aug; 28(2):151-3. PubMed ID: 16815688
    [No Abstract]   [Full Text] [Related]  

  • 16. Standardized intraabdominal abscess formation with generalized sepsis: pathophysiology in the rat.
    Hansson L; Alwmark A; Christensen P; Jeppsson B; Holst E; Bengmark S
    Eur Surg Res; 1985; 17(3):155-9. PubMed ID: 3888637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic lethality in experimental infections with Escherichia coli and Bacteroides fragilis.
    Rodloff AC; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Oct; 258(1):112-9. PubMed ID: 6395577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis.
    Bartlett JG; Louie TJ; Gorbach SL; Onderdonk AB
    Rev Infect Dis; 1981; 3(3):535-42. PubMed ID: 7025151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.